551 / 1024
Lymph node
metastasized prostate cancer
•
N=80
•
T1-4, N1M0
•
Intensity modulated arc radiotherapy (IMAT) + androgen
deprivation
•
Dose: 69,3 Gy in 25 fractions; SIB (intraprostatic lesion): 72 Gy
•
F/u: 3 years
•
3-year late grade 3 GI: 8%
•
3-year late grade 3/4 GU: 6%
•
3-year bRFS and cRFS was 81% and 89%, respectively.
Radiotherapy and Oncology 109 (2013) 229–234